These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7126542)

  • 21. Importance of the 10-13 region of glucagon for its receptor interactions and activation of adenylate cyclase.
    Krstenansky JL; Trivedi D; Hruby VJ
    Biochemistry; 1986 Jul; 25(13):3833-9. PubMed ID: 3017406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation of glucagon, characterization of the sulfonium derivative, and regeneration of the native covalent structure.
    Rothgeb TM; Jones BN; Hayes DF; Gurd RS
    Biochemistry; 1977 Dec; 16(26):5813-8. PubMed ID: 588556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of an essential serine residue in glucagon: implication for an active site triad.
    Unson CG; Merrifield RB
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):454-8. PubMed ID: 8290548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semisynthetic glucagon derivatives for structure-function studies.
    Hruby VJ; Wright DE; Lin MC; Rodbell M
    Metabolism; 1976 Nov; 25(11 Suppl 1):1323-5. PubMed ID: 185491
    [No Abstract]   [Full Text] [Related]  

  • 25. Preparation and properties of glucagon analogs prepared by semi-synthesis from CNBr-glucagon.
    Wright DE; Hruby VJ; Rodbell M
    Biochim Biophys Acta; 1980 Aug; 631(1):49-58. PubMed ID: 6249392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-conformation-activity studies of glucagon and semi-synthetic glucagon analogs.
    Hruby VJ
    Mol Cell Biochem; 1982 Apr; 44(1):49-64. PubMed ID: 6283336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological activities of des-His1[Glu9]glucagon amide, a glucagon antagonist.
    Unson CG; Gurzenda EM; Merrifield RB
    Peptides; 1989; 10(6):1171-7. PubMed ID: 2560175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of fully active biotinylated analogues of parathyroid hormone and parathyroid hormone-related protein as tools for the characterization of parathyroid hormone receptors.
    Roubini E; Duong LT; Gibbons SW; Leu CT; Caulfield MP; Chorev M; Rosenblatt M
    Biochemistry; 1992 Apr; 31(16):4026-33. PubMed ID: 1314656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iodoglucagon. Preparation and characterization.
    Desbuquois B
    Eur J Biochem; 1975 May; 53(2):569-80. PubMed ID: 1140201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (Des-histidine 1) (N epsilon-phenylthiocarbamoyllysine 12)-glucagon: effects on glycogenolysis in perfused rat liver.
    Khan BA; Bregman MD; Nugent CA; Hruby VJ; Brendel K
    Biochem Biophys Res Commun; 1980 Apr; 93(3):729-36. PubMed ID: 7387671
    [No Abstract]   [Full Text] [Related]  

  • 31. Purification of the photoaffinity-labeled glucagon receptor by gel electrophoretic methods.
    Horuk R; Beckner S; Lin M; Wright DE; Chrambach A
    Prep Biochem; 1984; 14(2):99-121. PubMed ID: 6091090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipolytic and adenyl-cyclase-stimulating activity of glucagon 1-6: comparison with glucagon derivatives chemically modified in the 7-29 sequence.
    Jean-Baptiste E; Rizack MA; Epand RM
    Biosci Rep; 1982 Oct; 2(10):819-24. PubMed ID: 7171745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies against specific extracellular epitopes of the glucagon receptor block glucagon binding.
    Unson CG; Cypess AM; Wu CR; Goldsmith PK; Merrifield RB; Sakmar TP
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):310-5. PubMed ID: 8552628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of potent glucagon antagonists: structure-activity relationship study of glycine at position 4.
    Ahn JM; Medeiros M; Trivedi D; Hruby VJ
    J Pept Res; 2001 Aug; 58(2):151-8. PubMed ID: 11532074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and properties of porcine relaxin derivatives shortened at the amino terminus of the A chain.
    Büllesbach EE; Schwabe C
    Biochemistry; 1986 Oct; 25(20):5998-6004. PubMed ID: 3790502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity studies on the N-terminal region of glucagon.
    Sueiras-Diaz J; Lance VA; Murphy WA; Coy DH
    J Med Chem; 1984 Mar; 27(3):310-5. PubMed ID: 6699876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-function relationships of S-carboxymethyl methionine27 glucagon.
    Cornely KA; Shelter KA; England RD; Horwitz EM; Gurd RS
    Arch Biochem Biophys; 1985 Aug; 240(2):698-704. PubMed ID: 2992382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipolytic and adenyl-cyclase-stimulating activity of N alpha-trinitrophenyl glucagon: comparison with other glucagon derivatives modified at the amino terminus.
    Jean-Baptiste E; Rizack MA; Epand RM
    Biosci Rep; 1982 Mar; 2(3):163-7. PubMed ID: 7066487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-ethylmaleimide uncouples the glucagon receptor from the regulatory component of adenylyl cyclase.
    Lipson KE; Kolhatkar AA; Dorato A; Donner DB
    Biochemistry; 1986 Sep; 25(19):5678-85. PubMed ID: 3022802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physicochemical and biological properties of glucagon-like polypeptides from porcine colon.
    Conlon JM; Murphy RF; Buchanan KD
    Biochim Biophys Acta; 1979 Apr; 577(2):229-40. PubMed ID: 454644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.